Sedative, Hypnotic, or Anxiolytic Intoxication occurs when there is a clinically significant problematic behavioural or psychological change (e.g. - inappropriate sexual or aggressive behavior, mood lability, impaired judgment, impaired social or occupational functioning) that develops during, or shortly after ingestion of substances including benzodiazepines, benzodiazepine-like drugs (e.g. - zolpidem, zaleplon), carbamates (e.g. - glutethimide, meprobamate), barbiturates (e.g. - phenobarbital, secobarbital), and barbiturate-like hypnotics (e.g. - glutethimide, methaqualone).[1] This class also includes all prescription sleeping medications and almost all prescription anti-anxiety medications. Non-benzodiazepine anti-anxiety agents (e.g. - buspirone, gepirone) are not included in this class because they are not associated with significant misuse.
Recent use of a sedative, hypnotic, or anxiolytic.
Clinically significant maladaptive behavioural or psychological changes (e.g. - inappropriate sexual or aggressive behavior, mood lability, impaired judgment) that developed during, or shortly after, sedative, hypnotic, or anxiolytic use.
At least 1
of the following signs or symptoms developing during, or shortly after, sedative, hypnotic, or anxiolytic use:
The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication with another substance.
Guideline | Location | Year | Website | |
---|---|---|---|---|
Deprescribing.org | Canada | 2018 | • For Patients • For Prescribers | • For Patients • For Providers |
Canadian Guidelines on Benzodiazepine Receptor Agonist Use Disorder Among Older Adults | Canada | 2019 | Link | |
Australian Prescriber | Australia | 2015 | - | Link |